On 29 October 2024 in Copenhagen, Denmark, IFPMA and EFPIA delivered a statement at the 74th WHO Regional Committee for Europe on the WHO/Europe Access to Novel Medicines Platform.
Read moreOn 21 October 2024 in Cali, Colombia, IFPMA delivered an opening statement at the 16th meeting of the Conference of the Parties to the Convention on Biological Diversity.
Read moreOn 16 October 2024 in Geneva, IFPMA delivered a statement at the 36th meeting of WIPO’s Standing Committee on Patents:, on technology transfer.
Read moreOn 16 October 2024 in Geneva, IFPMA delivered a statement at the 36th meeting of WIPO’s Standing Committee on Patents: Patents and Health.
Read moreOn 16 October 2024 in Doha, Qatar, IFPMA delivered a statement at the 71st session of the WHO EMRO Regional Committee on Promoting collaborative action to accelerate the response to antimicrobial resistance in the Eastern Mediterranean Region.
Read moreOn 14 October 2024 in Doha, Qatar, IFPMA delivered a statement at the 71st session of the WHO EMRO Regional Committee on the Regional flagship initiative 1: Expanding equitable access to medical products.
Read moreOn 9 October 2024 in New Delhi, India, IFPMA delivered a statement at the 77th WHO SEARO Regional Committee on Agenda items 8.2 and 9.6: NCDs and UHC.
Read moreOn 3 October 2024 in Washington, D.C., IFPMA and FIFARMA delivered a statement at the 61st PAHO Directing Council on a report focused on access and rational use of strategic and high-cost medicines and other health technologies.
Read moreOn 3 October 2024, IFPMA and FIFARMA delivered a statement at the 61st Directing Council of the Pan American Health Organization (PAHO): Strategy on epidemic intelligence for strengthening early warning of health emergencies 2024-2029.
Read moreOn 26 September 2024, IFPMA submitted the following statement from the floor at the UN High-Level Meeting on AMR. Eight years after the first ever AMR high-level meeting we find ourselves at the precipice of turning the tide. The pharmaceutical industry heard the call to action at the first high-level meeting, and through establishing the...
Read moreIFPMA, with support and representation from industry leaders, joins stakeholders this week at the 11th Business Ethics for APEC SMEs Forum. This Forum – and the initiative on which it is based – supports the advancement of ethical business practices in the Asia-Pacific economies, with a focus on the health sector and wider health ecosystem....
Read moreAs Governments of EU Member States present their medium-term fiscal structural plans on 20 September, a new report developed by The European House – Ambrosetti, supported by IFPMA and Vaccines Europe, notes that embedding preventative healthcare – in particular immunisation – into EU Member States’ fiscal policies is paramount to ensure the economic sustainability of...
Read more